Charles River Laboratories Inte
CRL
Jodie situation report
Charles River Laboratories Inte's move is being confirmed by its market group.
CRL accounts for 7.3% of the group's measured movement across 9.2 effective names. raw member direction is mixed; 10 of 10 SPY-adjusted paths align to the upside. Capital-flow agreement is 39%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
BIO moved materially before CRL. CRL crossed its material path threshold at 10:45 ET. SHC, RGEN, MTD followed.
- Revenue decreased 2.7% versus the comparable filing period.
5 of 10 members in Healthcare Diagnostics are active. 0 of 8 disclosed connections are confirming.
- At least 7 of 10 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as BRKR begins moving with the group.
Invalidation: The live read weakens if participation falls to 3 of 10 members or fewer.
Who this business touches
The relationships behind CRL
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
WLKWestlake CorporationsupplierFeb 26, 2026 ▾
“Closures of Certain North American Chlorovinyls Facilities and Styrene Plant Facility In the fourth quarter of 2025, under our asset optimization initiative, we ceased operation of certain of our North American chlorovinyl production facilities, including (i)…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 17 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
CRL is currently a Participant in the organic co-movement group Healthcare Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.